Page 7 - 《中国药房》2020年22期

·药事管理·

国家高新技术产业开发区生物医药产业政策主题挖掘及量化评

价研究 Δ

#
＊
乔 晗 ，徐俐颖，李 旭，李树祥，褚淑贞（中国药科大学国家药物政策与医药产业经济中心，南京 211198）
中图分类号 R95；F426 文献标志码 A 文章编号 1001-0408（2020）22-2689-06
DOI 10.6039/j.issn.1001-0408.2020.22.01

摘 要 目的：为我国生物医药产业发展提供参考。方法：收集2010年1月－2019年12月我国全部169家国家高新技术产业开
发区（以下简称“国家高新区”）官方网站上发布的政策文件，从中筛选出专门针对生物医药产业方面的政策以及全部产业政策中
提及生物医药产业发展的政策，采用Excel 2019软件进行政策信息的汇总分析；使用Gensim包完成政策文本的预处理并构建隐
合狄利克雷分布（LDA）主题模型，实现对政策文本中潜在语义信息的提取与分析。结果：共收集到相关政策文本518件，其中有
效词汇共58 617个，高频词汇包括项目、人才、支持、补贴、创新等；提取出8个主题，按主题强度排序依次为技术创新、人才建设、
融资支持、项目金融支持、税收优惠、资源引领、出口贸易、中小企业建设，强度分别为 0.299、0.168、0.134、0.116、0.113、0.063、
0.058、0.049。结论：国家高新区生物医药产业政策以技术创新、人才建设和融资支持为主，缺乏对中小企业建设、资源引领、出口
贸易的关注。今后国家高新区对生物医药产业的政策支持及体系建设应重点完善政策激励措施，平衡各领域政策运用比例；鼓励
企业扩大海外市场，学习海外先进技术，加强科研等领域的多边合作；配套相应的政策以增进企业间的交流合作，发挥龙头企业和
名牌产品的带动作用，促进中小企业发展。
关键词 隐合狄利克雷分布主题模型；国家高新技术产业开发区；生物医药产业；政策；主题挖掘；量化评价
Study on the Subject Mining and Quantitative Evaluation of Biomedical Industry Policy in National
High-tech Industrial Development Zone
QIAO Han，XU Liying，LI Xu，LI Shuxiang，CHU Shuzhen（Research Center of National Drug Policy &
Ecosystem，China Pharmaceutical University，Nanjing 211198，China）

ABSTRACT OBJECTIVE：To provide reference for the development of biomedical industry in China. METHODS：The policies
and documents issued by 169 national high-tech industrial development zone（hereinafter reffered to as“National high-tech zone”）
official websites from Jan. 2010 to Dec. 2019 were collected to screen policies specifically for the biomedical industry and the
development policy of biomedical industry mentioned in all industrial policies. Excel 2019 software was used to summarize and
analyze policy information. Gensim package was used to preprocess the policy texts and construct LDA topic model to extract the
potential semantic information from the policy texts. RESULTS：A total of 518 policy texts were collected，including 58 617
effective words；high-frequency words included project，talent，support，subsidy，innovation，etc.；8 themes were extracted，
ranked by theme intensity as technological innovation，talent construction，financing support，project financial support，tax
incentives，resource guidance，export trade，and construction of small and medium-sized enterprises，with the intensities of 0.299，
0.168，0.134，0.116，0.113，0.063，0.058 and 0.049，respectively. CONCLUSIONS：The biomedical industry policy of the
national high-tech zone is mainly based on technological innovation，talent construction and financing support，and lacks attention
to the construction of small and medium-sized enterprises，resource guidance，and export trade. In the future，the national
high-tech zone’s policy support and system construction for the biomedical industry should focus on improving policy incentives
and balancing the proportion of policy applications in various fields；encourage enterprises to expand overseas markets，learn
overseas advanced technologies， and strengthen multilateral cooperation in scientific research and other fields；support the
corresponding policies to enhance exchanges and cooperation between enterprises，give play to the leading role of leading
enterprises and famous brand products，and promote the development of small and medium-sized enterprises.
KEYWORDS LDA topic model；National high-tech industrial development zone；Biomedical industry；Policy；Theme mining；
Quantitative evaluation

Δ 基金项目：国家社会科学基金重大项目（No.15ZDB167） 国家高新技术产业开发区（以下简称“国家高新
＊硕士研究生。研究方向：医药经济。E-mail：qh_4869su@163. 区”）作为改革开放以来我国经济体制改革的重要成果
com
之一，是我国高新技术产业孵化的重要基地。1988年经
# 通信作者：教授，硕士生导师。研究方向：医药产业经济与政
策。E-mail：csz77844@163.com 国务院批准，我国建立了首个高新区——中关村高新

中国药房 2020年第31卷第22期 China Pharmacy 2020 Vol. 31 No. 22 ·2689 ·